Genetic Technological Innovations LLC v. Myers

District Court, D. Arizona·Decided June 16, 2025·No. 2:24-cv-00838·Unknown

Opinion

WO

Genetic Technological Innovations LLC, No. CV-24-00838-PHX-JJT

Plaintiff, ORDER

v.

Christopher Myers,

Defendant. At issue is the Motion for Summary Judgment filed by Plaintiff Genetic Technological Innovations LLC (“GTI”) (Doc. 21, MSJ), supported by a Statement of Facts (Doc. 22, Pl.’s Statement of Facts (“PSOF”)). Defendant Christopher Myers filed a Response (Doc. 30, MSJ Resp.), supported by a Statement of Facts (Doc. 31), and Plaintiff filed a Reply (Doc. 32, MSJ Reply).1 Also at issue is Defendant’s Motion for Relief Under Rule 56(d) (Doc. 23, 56(d) Mot.), to which Plaintiff filed a Response (Doc. 26, 56(d) Resp.) and Defendant filed a Reply (Doc. 27, 56(d) Reply). The Court will resolve these Motions without oral argument. LRCiv 7.2(f). Defendant Christopher Myers owns Hermes Health Labs, LLC (“Hermes”), which he formed to provide clinical laboratory testing services. (Doc. 1, Compl. ¶ 6; Doc. 31 at 50–57, Def.’s Additional Material Facts (“DAMF”) ¶ 2.) In November 2022, Myers met Nick Glimcher, who owns Plaintiff GTI, a laboratory testing company operating in

1 The Court granted Defendant leave to file a Sur-Reply, but Defendant did not timely file one. (Doc. 36.) Arizona. (Compl. ¶ 1; DAMF ¶ 1.) On April 6, 2023, GTI and Hermes entered into a Revolving Loan Agreement (“RLA”) under which GTI agreed to extend Hermes a line of credit for $500,000. (PSOF ¶ 2; PSOF Ex. 2, RLA.) Concurrently, GTI and Hermes executed a Revolving Promissory Note setting forth the terms of Hermes’s repayment of the money GTI loaned it under the credit line. (PSOF Ex. 3, Note.) In addition, Myers, a company called Hermes Health Holdco, LLC—of which Myers is the founder—and a company called Hermes Health Sciences, LLC—of which Glimcher is the Chief Executive Officer—entered into a Guaranty Agreement in which those three parties agreed to act jointly and severally as Guarantors for repayment of the loan from Hermes to GTI. (PSOF Ex. 4, Guaranty Agreement.) Hermes failed to make the required payments to GTI under the terms of the Note, and GTI sent a Notice of Default to Hermes on September 25, 2023. (PSOF ¶¶ 16, 19–20.) After Hermes failed to pay the debt in full, GTI sought payment from Myers as one of the Guarantors based on the Guaranty Agreement’s provision that GTI could seek payment from any one or more of the Guarantors without exhausting GTI’s remedies against Hermes or any other party. (PSOF ¶¶ 12, 26.) After Myers failed to pay the debt in full as Guarantor, GTI filed this lawsuit raising a single claim for breach of contract against Myers2 and seeking damages in the form of payment of the remaining balance of the loan, interest, attorneys’ fees, and “any other monetary damages in an amount according to proof at trial.” (Compl. at 6, Prayer ¶¶ 1–4.) Myers avers that this is not the whole story. In his Declaration, he states that Glimcher represented to him that “GTI could set up, manage and assist Hermes with all of its laboratory set up needs and in short order.” (DAMF Ex. 1, Myers Decl. ¶ 4.) As a result,

2 In the Complaint’s “Causes of Action” section setting forth GTI’s “Breach of Contract” claim, GTI alleges that “Hermes breached the [RLA] and Promissory Note by failing to pay GTI the amounts it owes,” that “Myers, as the guarantor of each contract, breached the Guaranty by failing to pay GTI the amounts Hermes owes as he promised to do pursuant to the Guaranty,” and that “Defendant’s failures caused GTI damages.” (Compl. ¶¶ 25–26.) Because GTI only named and served Myers as Defendant and does not allege that the Court should disregard the corporate form such that Myers could be liable for Hermes’s alleged breach of the RLA and Note, the only breach of contract claim before the Court is Myers’s alleged breach of the Guaranty Agreement. Indeed, it is the only contract before the Court to which Myers is a party. “GTI and Hermes entered into an oral agreement, wherein GTI agreed to set up, manage, and supervise Hermes[’s] laboratory facility, including the procurement of all licenses and credentialling Hermes required to conduct and provide medical diagnostic testing, in exchange for a management services fee Hermes agreed to pay.” (Myers Decl. ¶ 6.) “GTI asked that while it was working to establish Hermes[’s] lab and the required credentialling, . . . Hermes refer all of its testing samples to GTI and GTI would run those samples through its facility. In exchange, GTI agreed to pay Hermes a referral fee.” (Myers Decl. ¶ 9.) To memorialize this agreement, GTI and Hermes entered into a Laboratory Management Agreement (“LMA”). (Myers Decl. Ex. A.) After they executed the LMA, Glimcher told Myers that “GMI could not pay Hermes directly for the referrals as GTI was obligated to under the LMA” because “doing so could violate various medical referral statutes, including the Physician Self-Referral Law, also known as the Stark Law.” (Myers Decl. ¶¶ 13–14.) So Glimcher proposed to Myers that Hermes enter into the RLA to set up a line of credit that “would operate as an offset against the referral fees that GTI owed Hermes,” which Myers agreed to. (Myers Decl. ¶¶ 15–16.) In his Declaration, Myers makes no mention of his decision to individually execute the Guaranty Agreement, but he signed the Guaranty on his own behalf the same day he signed the RLA and Note on behalf of Hermes. (PSOF Exs. 2–4.) Myers avers that, rather than pay Hermes its referral revenues by way of a line-of- credit/RLA offset, GTI “concocted bogus charges” against Hermes such that it owed Hermes no money under the LMA, even though Myers claims Hermes was entitled to over $1 million in revenue over the relevant period. (Doc. 31, DSOF ¶ 46; Myers Decl. ¶ 54.) Myers also claims that GTI intentionally delayed obtaining the promised credentialling on behalf of Hermes such that Hermes was delayed in starting to conduct its own testing and bring in the associated revenue. (Doc. 31, DSOF ¶ 46; Myers Decl. ¶ 54.) Hermes thus had to borrow money against the line of credit “to stay afloat” and, because it did not have incoming revenue, it could not meet the repayment schedule under the Note. (DSOF ¶ 46.) . . . Myers claims that GTI made “knowingly false representations” about the necessity and purpose of the line of credit, such that he was induced to enter into the RLA “under false pretenses.” (Myers Decl. ¶¶ 52, 54.) In his Answer to the Complaint, Myers raises numerous affirmative defenses to GTI’s breach of the Guaranty Agreement claim, including unclean hands, equitable estoppel, waiver, accord and satisfaction, ratification, acquiescence, account stated, payment, unilateral or mutual mistake, and part or full performance. (Doc. 15, Answer at 5–7.) Myers also contends that GTI breached the LMA, and that claim is subject to arbitration under the terms of that agreement, which Hermes has initiated against GTI. (MSJ Resp. at 4.) The Court held a Rule 16 case management conference in this matter on August 22, 2024, and entered a Scheduling Order setting a dispositive motion deadline of August 6, 2025, and a discovery deadline of September 8, 2025. (Docs. 19, 20.) GTI filed its present Motion for Summary Judgment about six weeks later, on October 4, 2024, after the parties had exchanged initial disclosures but before they had conducted any discovery. (MSJ; 56(d) Mot. at 2.) In addition to filing a Response to GTI’s Motion for Summary Judgment, Myers has filed a Motion for Relief requesting that the Court defer ruling on, or deny, GTI’s Motion under Federal Rule of Civil Procedure 56(d) so that the parties have the opportunity to conduct discovery. (56(d) Mot. at 10.) The Court now addresses the pending Motion for Summary Judgment and Rule 56(d) Motion for Relief. Under

Genetic Technological Innovations LLC v. Myers, (D. Ariz. 2025).

Genetic Technological Innovations LLC v. Myers (Genetic Technological Innovations LLC v. Myers) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Klaxon Co. v. Stentor Electric Manufacturing Co.
313 U.S. 487 (Supreme Court, 1941)
Torres v. City of Madera
648 F.3d 1119 (Ninth Circuit, 2011)
Swanson v. Image Bank, Inc.
77 P.3d 439 (Arizona Supreme Court, 2003)
Dietel v. Day
492 P.2d 455 (Court of Appeals of Arizona, 1972)
Standage v. Standage
711 P.2d 612 (Court of Appeals of Arizona, 1985)
Bryant v. Silverman
703 P.2d 1190 (Arizona Supreme Court, 1985)
Howard v. Associated Grocers
601 P.2d 593 (Arizona Supreme Court, 1979)
Tenet Healthsystem TGH, Inc. v. Silver
52 P.3d 786 (Court of Appeals of Arizona, 2002)
Loiselle v. COSAS MANAGEMENT GROUP, LLC
228 P.3d 943 (Court of Appeals of Arizona, 2010)
State v. Angelo
800 P.2d 11 (Court of Appeals of Arizona, 1990)
Fresno Motors, LLC v. Mercedes-Benz USA, LLC
771 F.3d 1119 (Ninth Circuit, 2014)
Thomas v. Hoffman
9 P.2d 538 (California Court of Appeal, 1932)